N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. (2014)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00228-014-1703-0
PubMed Identifier: 24888881
Publication URI: http://europepmc.org/abstract/MED/24888881
Type: Journal Article/Review
Volume: 70
Parent Publication: European journal of clinical pharmacology
Issue: 9
ISSN: 0031-6970